C
CorNeat Vision
Permanent Tissue-Integrating Implants
About CorNeat Vision
CorNeat Vision is a medical device company developing and marketing novel, permanent and tissue-integrating implants. Our platform material technology, CorNeat EverMatrix™, overcomes the main issue with implants and implantables – the foreign body response they trigger.
The EverMatrix™ seamlessly and permanently embeds with live tissue without triggering an inflammatory response. Its durability and flexibility, coupled with its bio-integration capabilities, mark a new era of implants.
The EverMatrix™ is set to displace harvested and processed human and animal tissues, including scaffolds and extra cellular matrices, used in a variety of surgical procedures across diversified fields of medicine.
CorNeat KPro: The CorNeat KPro is a novel self-integrating artificial cornea solution that enables corneally blind patients to regain sight and fully enjoy their vision potential without relying on donor tissue. The implant leverages a synthetic, tissue-integrating and biomimetic skirt and a straightforward surgical procedure, hence can scale globally to address the acute global shortage in donor tissue.
CorNeat EverPatch: The FDA cleared CorNeat EverPatch is the first non-degradable synthetic tissue substitute for ophthalmic surgery. It eliminates the need for scleral patches and processed tissue patches used in a variety of ophthalmic procedures.
CorNeat eShunt: The CorNeat eShunt is a tissue-integrating glaucoma drainage device that extends minimally invasive surgery to severe and refractory glaucoma patients. Unlike the current standard of care, the CorNeat eShunt’s patented drainage mechanism and drainage site are designed to provide predictable pressure reduction with enduring efficacy, while reducing the risk of hypotony.
CorNeat gPatch: The CorNeat gPatch is the only permanent membrane for gingival tissue reinforcement and guided tissue and bone regeneration. The CorNeat gPatch presents a paradigm shift in periodontology, as it also addresses long term complications around implants by providing a robust infrastructure for gum tissue.
Source: Dealroom company dataAt a glance
- Founded
- 2015
- Headquarters
- Ra'anana, Israel
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CorNeat Vision on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CorNeat Vision on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.